59 related articles for article (PubMed ID: 8765178)
1. Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.
Okusaka T; Okada S; Ishii H; Nose H; Nakasuka H; Nakayama H; Nagahama H
Jpn J Clin Oncol; 1996 Aug; 26(4):215-20. PubMed ID: 8765178
[TBL] [Abstract][Full Text] [Related]
2. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
Hepatogastroenterology; 1999; 46(30):3244-8. PubMed ID: 10626195
[TBL] [Abstract][Full Text] [Related]
3. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
Kosakamoto H; Okada S; Ueno H; Okusaka T; Ikeda M; Tanaka N; Yoshimori M; Matsuno Y
Hepatogastroenterology; 1999; 46(28):2621-4. PubMed ID: 10522052
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of therapeutic effect of chemotherapy with reference to clinical benefit response].
Okada S
Gan To Kagaku Ryoho; 2000 May; 27(5):696-701. PubMed ID: 10832437
[TBL] [Abstract][Full Text] [Related]
5. FP therapy for controlling malignant ascites in advanced pancreatic cancer patients.
Yonemori K; Okusaka T; Ueno H; Morizane C; Takesako Y; Ikeda M
Hepatogastroenterology; 2007 Dec; 54(80):2383-6. PubMed ID: 18265670
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
8. Marginal effects of regional intra-arterial chemotherapy as an alternative treatment option in advanced pancreatic carcinoma.
Meyer F; Grote R; Lippert H; Ridwelski K
Langenbecks Arch Surg; 2004 Feb; 389(1):32-9. PubMed ID: 14655016
[TBL] [Abstract][Full Text] [Related]
9. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
[TBL] [Abstract][Full Text] [Related]
10. [Biweekly low-dose cisplatin and 5-fluorouracil combination chemotherapy for advanced gastrointestinal carcinoma].
Kamata T; Morita A; Nakamoto A; Onishi I; Takeda T; Koyasaki N; Kanno M
Gan To Kagaku Ryoho; 2000 Jun; 27(6):859-64. PubMed ID: 10897212
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
12. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of antitumor effect of chemotherapy for pancreatic cancer].
Okada S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2031-5. PubMed ID: 9388510
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
[No Abstract] [Full Text] [Related]
15. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India.
Babu KG; Chaudhuri T; Lakshmaiah KC; Dasappa L; Jacob LA; Babu M; Rudresha AH; Lokesh KN; Rajeev LK
Indian J Cancer; 2017; 54(1):47-51. PubMed ID: 29199662
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy in adenocarcinomas of the pancreas].
Huguier M
Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
[No Abstract] [Full Text] [Related]
19. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]